Rufloksacin

Rufloksacin

Klinički podaci
AHFS/Drugs.com	Monografija
Identifikatori
CAS broj	101363-10-4
ATC kod	J01MA10
PubChem[1][2]	58258
UNII	Y521XM2900 Y
ChEMBL[3]	CHEMBL295619 Y
Hemijski podaci
Formula	C17H18FN3O3S
Mol. masa	363,407
SMILES	eMolekuli & PubHem
InChI InChI=1S/C17H18FN3O3S/c1-19-2-4-20(5-3-19)14-12(18)8-10-13-16(14)25-7-6-21(13)9-11(15(10)22)17(23)24/h8-9H,2-7H2,1H3,(H,23,24) Key: NJCJBUHJQLFDSW-UHFFFAOYSA-N Y
Sinonimi	7-Fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Rufloksacin je organsko jedinjenje, koje sadrži 17 atoma ugljenika i ima molekulsku masu od 363,407 Da.

1. ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
2. ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
3. ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit